{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:56:11Z","timestamp":1772898971072,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Technology Project of Guangzhou City","award":["201607010123"],"award-info":[{"award-number":["201607010123"]}]},{"name":"Scientific Research Project of Military Logistics Department","award":["CLB20J032"],"award-info":[{"award-number":["CLB20J032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Military Med Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Until January 18, 2021, coronavirus disease-2019 (COVID-19) has infected more than 93 million individuals and has caused a certain degree of panic. Viral pneumonia caused by common viruses such as respiratory syncytial virus, rhinovirus, human metapneumovirus, human bocavirus, and parainfluenza viruses have been more common in children. However, the incidence of COVID-19 in children was significantly lower than that in adults. The purpose of this study was to describe the clinical manifestations, treatment and outcomes of COVID-19 in children compared with those of other sources of viral pneumonia diagnosed during the COVID-19 outbreak.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Children with COVID-19 and viral pneumonia admitted to 20 hospitals were enrolled in this retrospective multi-center cohort study. A total of 64 children with COVID-19 were defined as the COVID-19 cohort, of which 40 children who developed pneumonia were defined as the COVID-19 pneumonia cohort. Another 284 children with pneumonia caused by other viruses were defined as the viral pneumonia cohort. The epidemiologic, clinical, and laboratory findings were compared by Kolmogorov-Smirnov test, t-test, Mann-Whitney U test and Contingency table method. Drug usage, immunotherapy, blood transfusion, and need for oxygen support were collected as the treatment indexes. Mortality, intensive care needs and symptomatic duration were collected as the outcome indicators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared with the viral pneumonia cohort, children in the COVID-19 cohort were mostly exposed to family members confirmed to have COVID-19 (53\/64 vs. 23\/284), were of older median age (6.3 vs. 3.2\u2009years), and had a higher proportion of ground-glass opacity (GGO) on computed tomography (18\/40 vs. 0\/38,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u20090.001). Children in the COVID-19 pneumonia cohort had a lower proportion of severe cases (1\/40 vs. 38\/284,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.048), and lower cases with high fever (3\/40 vs. 167\/284,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u20090.001), requiring intensive care (1\/40 vs. 32\/284,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u20090.047) and with shorter symptomatic duration (median 5 vs. 8 d,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u20090.001). The proportion of cases with evaluated inflammatory indicators, biochemical indicators related to organ or tissue damage, D-dimer and secondary bacterial infection were lower in the COVID-19 pneumonia cohort than those in the viral pneumonia cohort (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u20090.05). No statistical differences were found in the duration of positive PCR results from pharyngeal swabs in 25 children with COVID-19 who received antiviral drugs (lopinavir-ritonavir, ribavirin, and arbidol) as compared with duration in 39 children without antiviral therapy [median 10 vs. 9 d,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.885].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The symptoms and severity of COVID-19 pneumonia in children were no more severe than those in children with other viral pneumonia. Lopinavir-ritonavir, ribavirin and arbidol do not shorten the duration of positive PCR results from pharyngeal swabs in children with COVID-19. During the COVID-19 outbreak, attention also must be given to children with infection by other pathogens infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40779-021-00306-7","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T02:38:54Z","timestamp":1613788734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of acute pneumonia caused by SARS-COV-2 and other respiratory viruses in children: a retrospective multi-center cohort study during COVID-19 outbreak"],"prefix":"10.1016","volume":"8","author":[{"given":"Guang-Li","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Qiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Chun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-He","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Xin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Zong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Ling","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben-Qing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Mao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Zhong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"issue":"4","key":"306_CR1","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jmv.25681","volume":"92","author":"Y Chen","year":"2020","unstructured":"Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418\u201323.","journal-title":"J Med Virol"},{"issue":"9371","key":"306_CR2","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0140-6736(03)13410-1","volume":"361","author":"CA Donnelly","year":"2003","unstructured":"Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, Riley S, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003;361(9371):1761\u20136.","journal-title":"Lancet."},{"issue":"1","key":"306_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S1473-3099(13)70304-9","volume":"14","author":"S Cauchemez","year":"2014","unstructured":"Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, Rambaut A, et al. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis. 2014;14(1):50\u20136.","journal-title":"Lancet Infect Dis"},{"issue":"13","key":"306_CR4","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","volume":"382","author":"Q Li","year":"2020","unstructured":"Li Q, Guan XH, Wu P, Wang XY, Zhou L, Tong YQ, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199\u2013207.","journal-title":"N Engl J Med"},{"key":"306_CR5","unstructured":"Who. WHO coronavirus disease (COVID-19) dashboard. https:\/\/covid19.who.int\/. Accessed 18 Jan 2021."},{"issue":"13","key":"306_CR6","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"ZY Wu","year":"2020","unstructured":"Wu ZY, Mcgoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239\u201342.","journal-title":"JAMA."},{"issue":"6","key":"306_CR7","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/cid\/ciaa198","volume":"71","author":"C Jiehao","year":"2020","unstructured":"Jiehao C, Jin X, Daojiong L, Zhi Y, Lei X, Zhenghai Q, et al. A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis. 2020;71(6):1547\u201351. https:\/\/doi.org\/10.1093\/cid\/ciaa198.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"306_CR8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1473-3099(20)30198-5","volume":"20","author":"HY Qiu","year":"2020","unstructured":"Qiu HY, Wu JH, Hong L, Luo YL, Song QF, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020;20(6):689\u201396.","journal-title":"Lancet Infect Dis"},{"issue":"17","key":"306_CR9","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMc2005073","volume":"382","author":"XX Lu","year":"2020","unstructured":"Lu XX, Zhang LQ, Du H, Zhang JJ, Li YY, Qu JY, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020;382(17):1663\u20135.","journal-title":"N Engl J Med"},{"key":"306_CR10","unstructured":"China National Health Commission. Diagnosis and treatment guidelines for 2019 novel coronavirus pneumonia (draft version 7). 2020; http:\/\/www.nhc.gov.cn\/yzygj\/s7653p\/202003\/46c9294a7dfe4cef80dc7f5912eb1989.shtml. Accessed 8 May 2020."},{"issue":"12","key":"306_CR11","first-page":"6","volume":"12","author":"China National Health Commission","year":"2019","unstructured":"China National Health Commission. Guideline for diagnosis and treatment of community-acquired pneumonia in children (2019 version). Chin J Clin Infect Dis. 2019;12(12):6\u201313.","journal-title":"Chin J Clin Infect Dis"},{"issue":"1","key":"306_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/jpids\/piw091","volume":"7","author":"C Stockmann","year":"2018","unstructured":"Stockmann C, Ampofo K, Killpack J, Williams DJ, Edwards KM, Grijalva CG, et al. Procalcitonin accurately identifies hospitalized children with low risk of bacterial community-acquired pneumonia. J Pediatric Infect Dis Soc. 2018;7(1):46\u201353.","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"11","key":"306_CR13","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"DW Wang","year":"2020","unstructured":"Wang DW, Hu B, Hu C, Zhu FF, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061\u20139.","journal-title":"JAMA"},{"issue":"5","key":"306_CR14","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00259-020-04735-9","volume":"47","author":"X Xu","year":"2020","unstructured":"Xu X, Yu CC, Qu J, Zhang LG, Jiang SF, Huang DY, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging. 2020;47(5):1275\u201380.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"306_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00247-003-1081-8","volume":"34","author":"PS Babyn","year":"2004","unstructured":"Babyn PS, Chu WCW, Tsou IYY, Wansaicheong GKL, Allen U, Bitnun A, et al. Severe acute respiratory syndrome (SARS): chest radiographic features in children. Pediatr Radiol. 2004;34(1):47\u201358.","journal-title":"Pediatr Radiol"},{"issue":"6","key":"306_CR16","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-0702","volume":"145","author":"Y Dong","year":"2020","unstructured":"Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145(6):e20200702. https:\/\/doi.org\/10.1542\/peds.2020-0702.","journal-title":"Pediatrics."},{"issue":"18","key":"306_CR17","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708\u201320.","journal-title":"N Engl J Med"},{"issue":"10223","key":"306_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"CL Huang","year":"2020","unstructured":"Huang CL, Wang YM, Li XW, Ren LL, Zhao JP, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"Lancet"},{"issue":"5","key":"306_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","volume":"20","author":"XT Cao","year":"2020","unstructured":"Cao XT. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20(5):269\u201370.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"306_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","volume":"136","author":"CK Wong","year":"2004","unstructured":"Wong CK, Lam CWK, Wu AKL, Ip WK, Lee NLS, Chan IHS, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol. 2004;136(1):95\u2013103.","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"306_CR21","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/nm.3362","volume":"19","author":"D Falzarano","year":"2013","unstructured":"Falzarano D, De Wit E, Rasmussen AL, Feldmann F, Okumura A, Scott DP, et al. Treatment with interferon-alpha 2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med. 2013;19(10):1313\u20137.","journal-title":"Nat Med"},{"issue":"1","key":"306_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12879-017-2272-5","volume":"17","author":"CF Shen","year":"2017","unstructured":"Shen CF, Wang SM, Ho TS, Liu CC. Clinical features of community acquired adenovirus pneumonia during the 2011 community outbreak in southern Taiwan: role of host immune response. BMC Infect Dis. 2017;17(1):196. https:\/\/doi.org\/10.1186\/s12879-017-2272-5.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"306_CR23","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s41564-019-0421-x","volume":"4","author":"EV Mesev","year":"2019","unstructured":"Mesev EV, Ledesma RA, Ploss A. Decoding type I and III interferon signalling during viral infection. Nat Microbiol. 2019;4(6):914\u201324.","journal-title":"Nat Microbiol"},{"issue":"10229","key":"306_CR24","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, Mcauley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033\u20134.","journal-title":"Lancet."},{"key":"306_CR25","doi-asserted-by":"publisher","first-page":"j686","DOI":"10.1136\/bmj.j686","volume":"356","author":"IJ Haq","year":"2017","unstructured":"Haq IJ, Battersby AC, Eastham K, Mckean M. Community acquired pneumonia in children. BMJ. 2017;356:j686.","journal-title":"BMJ."}],"container-title":["Military Medical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40779-021-00306-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40779-021-00306-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40779-021-00306-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:52:23Z","timestamp":1772830343000},"score":1,"resource":{"primary":{"URL":"https:\/\/mmrjournal.biomedcentral.com\/articles\/10.1186\/s40779-021-00306-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["306"],"URL":"https:\/\/doi.org\/10.1186\/s40779-021-00306-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-42751\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-42751\/v2","asserted-by":"object"}]},"ISSN":["2054-9369"],"issn-type":[{"value":"2054-9369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,16]]},"assertion":[{"value":"15 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was reviewed and approved by the Medical Ethics Committee of General Hospital of Southern Theater Command of Chinese People\u2019s Liberation Army (approval number 2020\u201304). Signed informed consent of participants or their guardians was waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}